- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/5513 - 1,4-Benzodiazepines, e.g. diazepam
Patent holdings for IPC class A61K 31/5513
Total number of patents in this class: 1443
10-year publication summary
|
125
|
105
|
113
|
112
|
168
|
137
|
132
|
151
|
134
|
26
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| GW Research Limited | 402 |
34 |
| Bristol-myers Squibb Company | 5080 |
33 |
| The Regents of the University of California | 18943 |
33 |
| Alkermes Pharma Ireland Limited | 307 |
25 |
| Nippon Chemiphar Co., Ltd. | 233 |
20 |
| Ayala Pharmaceuticals Inc. | 25 |
20 |
| Enanta Pharmaceuticals, Inc. | 420 |
18 |
| Boehringer Ingelheim International GmbH | 4629 |
17 |
| Ovid Therapeutics Inc | 151 |
15 |
| Pfizer Inc. | 3322 |
12 |
| Neurelis, Inc. | 49 |
12 |
| The Johns Hopkins University | 5377 |
11 |
| io Therapeutics, Inc. | 112 |
11 |
| Clexio Biosciences Ltd. | 101 |
11 |
| Novartis AG | 11238 |
10 |
| F. Hoffmann-La Roche AG | 7958 |
10 |
| Janssen Pharmaceutica N.V. | 3839 |
10 |
| Dana-Farber Cancer Institute, Inc. | 2455 |
10 |
| Aquestive Therapeutics, Inc. | 160 |
10 |
| The Regents of the University of Michigan | 4409 |
9 |
| Other owners | 1112 |